Fourth dose approved for immunocompromised individuals


Greece’s National Vaccination Committee approved on Tuesday the administration of a fourth dose of a coronavirus vaccine to immunocompromised people.

The experts decided that this group will be able to get the fourth jab 3-6 months after the third.

The decision concerns patients with haematological and oncological illnesses who under treatment, people receiving immunosuppressive drugs, transplant recipients and patients with rheumatic diseases or renal failure.